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Introduction & objectives
To describe psychological status in melanoma patients
in a high risk distress moment: the follow up consulta-
tion. Secondly to know if there are any difference in dis-
tress and in other psychological variables between
melanoma patients at stage Ib-II vs 0-Ia AJCC (Ameri-
can Joint Committed Cancer) and to correlate these
with clinical variables.
Material & methods
We recluted 204 continuous patients in 0-I-II melanoma
stages during the follow-up visit from March to June
2011. They were submitted to a psychological interview
and questionnaires (Distress Thermometer, Hospital
Anxiety Depression Scale, Montgomery-Asberg Depres-
sion Rating Scale, SF-36, Brief cope). Patients were
divided into two groups based on the stage of disease to
achieve our second aim (0-Ia vs Ib -II AJCC).
Results
The prevalence of distress, anxious and depressive
symptoms was detected in 8-44% of the sample. These
range is formed by: distress (44,1%), anxious symptoms
(25%) and depression symptoms (8,8%) measured both
with HADS, while we used the Montgomery-Asberg
Depression Rating Scale to evaluated depression. Glob-
ally, high values at the SF-36 test were demonstrated,
reporting a good quality of life in lower stages AJCC
melanoma patients.
The Brief Cope measured styles of coping that is a psy-
chological construct that express the way to face problems
and stressful events in our life. Denial coping style resulted
significantly correlated with distress, anxious and depressive
symptoms and worse quality of life. On the other hand, a
bad quality of life seems to influence negatively the psycho-
logical status of patients. Of them, who used active coping
was more able to face the pathology and reported better
psychological arrangement in their life.
Comparing the two groups (0-Ia vs Ib-II AJCC) about
levels of distress, anxious and depressive symptom, coping
styles and quality of life we found no statistically significant
differences regarding psychological distress, measured with
the Distress Thermometer and there were no statistically
significant differences for anxious or depressive symptoms,
measured with HADS. Quality of life, measured with
SF-36, revealed no significant differences between the two
groups. There were no statistically significant differences
between the two groups with regard to coping styles in the
majority of subscales of the Brief Cope questionnaire.
Conclusions
This work shows the presence of psychological distress
also in first stages melanoma patients population, suggest-
ing the importance of psychological screening also in low
risk melanoma patients. Moreover the findings corrobo-
rates that subjective factors, as the way of facing the
pathology, are more associated with the adjustment of
melanoma survivors than objective medical ones.
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